|
HS Code |
221111 |
| Active Ingredient | Tylvalosin Tartrate |
| Formulation | Premix |
| Appearance | Light yellow to yellow powder |
| Use | Veterinary antibiotic |
| Target Animals | Swine and poultry |
| Main Application | Prevention and treatment of respiratory and enteric infections |
| Administration Route | Oral, mixed with feed |
| Storage Conditions | Keep in a dry, cool, and dark place |
| Withdrawal Period | 5 days for swine, 3 days for poultry (may vary by country) |
| Mechanism Of Action | Inhibits bacterial protein synthesis |
| Spectrum Of Activity | Effective against Mycoplasma, Gram-positive bacteria, and some Gram-negative bacteria |
| Dosage | Usually 1-2 kg per ton of feed (exact dosage per veterinary guidance) |
| Package Sizes | Commonly available in 25 kg bags |
| Regulatory Status | Prescription veterinary drug in many countries |
| Solubility | Slightly soluble in water |
As an accredited Tylvalosin Tartrate Premix factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Tylvalosin Tartrate Premix is packaged in a sealed, foil-lined 1 kg bag, clearly labeled with product name, batch, and expiry date. |
| Container Loading (20′ FCL) | Container Loading (20′ FCL) for Tylvalosin Tartrate Premix: Packed in 25kg bags, 20 pallets, total net weight approx. 16 metric tons. |
| Shipping | Tylvalosin Tartrate Premix should be shipped in tightly sealed, original packaging to protect it from moisture and contamination. It must be kept in a cool, dry place away from direct sunlight and incompatible substances. Handle with care, following all applicable transportation regulations for veterinary pharmaceuticals. Avoid mechanical shock during transit. |
| Storage | Tylvalosin Tartrate Premix should be stored in a tightly closed, original container, protected from moisture, light, and direct sunlight. Keep in a cool, dry place, ideally below 25°C (77°F), and away from incompatible substances. Ensure storage areas are well-ventilated and access is restricted to authorized personnel. Keep out of reach of children and animals. |
| Shelf Life | Shelf life of Tylvalosin Tartrate Premix is typically 2 years when stored in a cool, dry place, away from sunlight. |
|
Purity 98%: Tylvalosin Tartrate Premix with purity 98% is used in swine feed, where it ensures high antimicrobial efficacy against Mycoplasma hyopneumoniae. Particle size ≤250 µm: Tylvalosin Tartrate Premix with particle size ≤250 µm is used in premix formulations, where it enables uniform distribution in animal feed. Stability temperature 40°C: Tylvalosin Tartrate Premix stable at 40°C is used in tropical storage conditions, where it maintains therapeutic potency during extended storage. Solubility 100 mg/mL: Tylvalosin Tartrate Premix with solubility 100 mg/mL is used in water-soluble premixes, where it allows rapid dispersion for medicated drinking water. Bulk density 0.45 g/cm³: Tylvalosin Tartrate Premix at bulk density 0.45 g/cm³ is used in automated feed manufacturing, where it minimizes dust formation during mixing. Moisture content ≤5%: Tylvalosin Tartrate Premix with moisture content ≤5% is used in long-term storage conditions, where it reduces risk of microbial contamination. Assay 97-103%: Tylvalosin Tartrate Premix with assay 97-103% is used in veterinary therapeutic protocols, where it provides accurate dosing for infection control. Melting point 205°C: Tylvalosin Tartrate Premix with melting point 205°C is used in pelleted feed processing, where it withstands short-term high-temperature exposure without degradation. |
Competitive Tylvalosin Tartrate Premix prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Each day at our plant, the rhythm of production carries a simple truth: a compound’s real value emerges only in the hands that use it. For those who work on farms, battling challenges rooted in animal health and overall productivity, Tylvalosin Tartrate Premix has become a dependable solution, achieving results that show up both in herd performance and in the bottom line. Years have passed since our first batches shipped out—years packed with animal health concerns that demanded practical thinking and a direct approach to product design.
Our Tylvalosin Tartrate Premix leaves the drying racks in the form of a fine, pale powder. This allows easy distribution in commercial feed mills, as well as consistency in medicated feeds. The most common specification runs at 20% tylvalosin tartrate by mass. That concentration has struck a workable balance: offering strong enough levels to intervene quickly in disease situations, while letting feed manufacturers maintain tight control over dosing in different formulas. In our observation, this 20% model has supported flexibility without causing issues in mixability or finished feed quality.
As a manufacturer, we don’t just see pallets and packaging—we field questions from veterinarians, farm consultants, and livestock managers with hundreds or thousands of animals relying on their judgment. Diseases caused by pathogens like Mycoplasma and certain bacteria remain top concerns in swine, poultry, and other operations. It’s in these routine yet high-stakes situations where tylvalosin tartrate separates itself from others in the toolbox. Tylvalosin’s mechanism of action, rooted in its macrolide structure, interrupts pathogen protein synthesis, suppressing disease outbreaks before they spiral. In application, this means fewer mortalities, reduced culling, steadier growth rates, and more efficient production cycles.
We’ve watched the impact firsthand. Several major outbreaks of pig respiratory disease in the region during humid summers underscored the cost of ineffective medication. During these critical periods, feed integrators and farmers often reported that switchovers to Tylvalosin Tartrate Premix resulted in a visible drop in coughing, a sharper appetite return in piglets, and quicker herd-wide stabilization. Oral administration through feed remains both practical and scalable in these contexts. As a component designed to travel seamlessly from the feed mill to the dosing bin, every batch we ship takes into account handling conditions on real farms and the limits of mixing machines, storage bins, and field labor capacity.
On the mixing floor and in quality testing, we respect one non-negotiable: consistency between bags, months, and years. Our 20% formulation isn’t a default—years of feedback drove us here. Producers who manage more than one barn requested a level strong enough to address outbreaks but safe for routine use. They highlighted the danger of feed segregation or powdering, so we focused research on improving dispersibility and avoiding clumps. Unlike coarse-crystal compounds, our premix’s particle size and free-flowing nature help minimize dust-up at the mixing stage and keep feed uniform all the way to the trough.
Multiple partners have asked for customized specifications, questioning if alternative concentrations or blends might cut costs or improve logistics. We always return to the same answer: shifting potency comes with trade-offs. At higher concentrations, dosing precision can become a challenge, especially in smaller-scale feed runs or where batch controls aren’t robust. At lower concentrations, bulk transport and storage costs rise, and the risks of underdosing mount, particularly in fast-moving feed lines. Through testing and bulk distribution feedback, the 20% standard has consistently satisfied both end users and compliance checkpoints. We remain open to specialty batches but always weigh demands against the realities of mixing, feed formulation, transport, and cost structure.
Each chemical plant worker learns quickly that impressive laboratory specifications sometimes collapse in real use. Humidity, temperature swings, and vibration on the road all undermine theoretical shelf life and powder texture. That’s why we pay close attention to moisture content and powder morphology, balancing hydroscopic resistance and flowability. Tylvalosin tartrate’s tartrate salt form allows greater water solubility compared to the base compound. This trait is invaluable during rainy months or in facilities reliant on moisture-prone storage. Fluctuations in warehouse climate can push even a good premix into clumping or caking if not formulated and finished with care.
Feedmills have flagged issues with certain antibiotic premixes that cause excessive dust or complete separation from feed, sending some of the active ingredient to the bottom of bags and bins. We modified our drying and milling sequences to tighten particle size distribution, which improved overall dust control and mixing profiles. Using batch records and bin samples, we’ve traced sharper homogeneity scores, reducing wasted product and customer complaints. Practical, feedback-driven improvements trumped theoretical efficiency gains. Where necessary, we integrated antioxidant stabilizers and fine-tuned the tartrate ratio, keeping both chemical stability and biological activity at the desired level through lengthy shipping and storage cycles.
It’s easy for outsiders to see antibacterial feed additives as all the same, but livestock operators see the distinction across compounds—both from a performance and operational standpoint. One persistent challenge in the market stems from cross-resistance. Decades of broad-spectrum product use in agriculture encouraged microbial adaptation. Many older tetracyclines and sulfa drugs now face widespread resistance, which erodes their return on investment and forces higher dosing or alternative solutions. Mode of action matters here. Tylvalosin belongs to the macrolide family and retains effectiveness even against strains that sideline unrelated drug classes.
Another difference stands out in withdrawal profiles and residue control. As regulatory rules toughen for meat safety, operators prize compounds that clear quickly from animal tissues. Tylvalosin tartrate’s metabolic pathway supports a shorter withdrawal period than older, fat-soluble antibiotics that linger in tissues like fat or skin. Our plant routinely collaborates with residue monitoring labs. Data from these partnerships guided us to keep impurity profiles below global targets and batch-to-batch variation within a fraction of set tolerances. By controlling the process end to end, we protect both animal health and the reputational risk facing food processors.
Practical differences also emerge in side effect frequency. Veterinary teams on the ground have flagged certain antibiotic blends for digestive upset, loss of feed conversion efficiency, or developmental issues in piglets or chicks. Our in-house and third-party animal trial data point to a low incidence of adverse reactions at standard dosing, and field feedback supports this record. This means fewer interventions and lower costs for follow-up treatments or lost productivity.
Livestock industries face heavier obligations today: faster traceability, strict residue controls, and tighter antibiotic stewardship. We run all batches of Tylvalosin Tartrate Premix through validation against national and international standards, tracking both chemical purity and biological potency. That includes verifying absence of undesirable byproducts, monitoring batch stability in accelerated aging chambers, and ensuring every bag matches minimum guaranteed active content. Producers in exporting countries demand assurances that align with fast-moving regulatory advice—meaning not only formal documentation, but prompt, open technical support from our team.
We routinely field requests for residue data, mixing test results, and details on ingredient origins. As an actual manufacturer, not a secondary handler, we control sourcing, processing, and logistics. Results go beyond paper guarantee—partners can audit our processes, request retention samples, or run independent checks using material sealed straight from our drying lines. This chain of control reassures both customers and regulators that every ton originated with us, not through a network of brokers or repackers.
From firsthand support visits and customer surveys, we gather insight into the practical realities of administering premixes on large and small farms alike. A full-blend premix like ours leverages efficiency: barn managers and feed mill operators don’t struggle with pre-dilution steps or the hazards of concentrated raw actives, reducing operator error and improving batch-to-batch accuracy. Dosing instructions align closely with field realities—optimizing for average daily intake and animal weights, rather than theoretical targets alone.
Farmers have highlighted time savings and fewer operator injuries when using properly structured premixes versus manual blending. Bagged premix reduces accidental inhalation of dust and supports straightforward measurement with standard equipment. Many users report less loss and better yield from medicated feeds compared with previous practices involving homemade blends or repacking from raw materials. We’ve adjusted packaging and sealing approaches based on feedback from tropical and subarctic conditions, extending shelf stability and reducing spoilage at the last-mile storage stage.
Safety doesn’t begin at the farm—it starts at the reactor and drying towers. Every production shift monitors for byproduct buildup and keeps a close eye on raw tartrate purity, solvent residues, and batch reaction temperature. Our QA/QC lab holds authority to halt shipments or trigger reprocessing if even minor irregularities occur. This approach not only protects end-users but keeps compliance within the strict confines of regulatory enforcement.
Understanding how end-users handle antibiotic feed additives drives our safety choices. We minimized bag residue and selected inner and outer packaging materials that withstand puncture, vibration, and moisture. The result: easier, cleaner handling and disposal for farms pressed for time and regulatory compliance. Instructions provided with shipments emphasize best practices for personal protective equipment and storage, based on actual incidents and feedback logged in our support database. Periodic updating ensures our safety advice remains practical and grounded in ongoing changes in industry incident reports.
The conversation around antibiotic stewardship grows more urgent every year. As a direct producer, we cannot ignore shifts toward reduced antibiotic reliance and improved targeted intervention. Our internal R&D team collaborates with independent academic groups to study the impacts of tylvalosin tartrate use in both outbreak and maintenance scenarios, particularly as gene mapping and disease surveillance trends evolve. We’re not satisfied resting on past results—continual process improvement drives both product stability and environmental controls at our facility, minimizing waste and meeting new emissions standards.
On the topic of environmental safety, all effluent and runoff streams from tylvalosin production face regular regulatory checks. As part of ongoing investment in greener chemistry, process upgrades target solvent recycling, powdered material capture, and reduced energy usage at every step. Years of practical audits drive our upgrades just as much as laboratory theory—experience shows what passes in small-scale runs often fails at ton-scale manufacturing. We communicate openly with supply chain partners about these measures, as transparency and accountability underpin lasting commercial relationships.
Field veterinarians, mill operators, and purchasing managers don’t want press releases—they want direct, practical answers. Our technical support responds with evidence, not just literature references. When a problem arises with a mixing process, we track it to the line, gather samples, and recommend changes that reflect what works, based on firsthand troubleshooting across different customer sites. End users routinely get updates on regulatory changes, new trial data, or product upgrades, delivered in plain language. Emergencies draw a rapid response—not just in replacing inventory, but in sharing specific handling instructions or troubleshooting advice based on site-specific conditions.
Across seasons and markets, our experience manufacturing and supplying Tylvalosin Tartrate Premix has shown that careful attention to formulation, quality, and customer feedback makes a real difference. The success of a medication in animal production doesn’t come from a molecule alone—it’s built through consistent control, responsiveness to user needs, and the drive to translate feedback into improvement. Every batch carries the hard-earned lessons of practical use: from the feed mill to the animal house, from regulatory audit to animal health recovery.
By respecting the realities of how farms operate, how feed is mixed, and how health challenges actually play out, we aim to deliver more than just a product—we deliver reliability, traceability, and proven results. That’s the daily work of a manufacturer, and that’s the story behind every shipment of Tylvalosin Tartrate Premix leaving our plant.